other · Figshare · 2020

Case-cohort sampling scheme.

Lindsay N. Carpp (8048906), Youyi Fong (519951), Matthew Bonaparte (3148182), Zoe Moodie (211088), Michal Juraska (688780), Ying Huang (53474), Brenda Price (3434561), Yingying Zhuang (1881535), Jason Shao (725172), Lingyi Zheng (8975660), Laurent Chambonneau (6083096), Robert Small (5346035), Saranya Sridhar (36740), Carlos A. DiazGranados (8486010), Peter B. Gilbert (7431215)

Cited by 0Open access

Abstract

<p>Controls are defined as participants who were randomly sampled into the immunogenicity subset (IS), had an available titer measurement, and completed the active phase (25 months post-first vaccination) without experiencing the DENV-Any endpoint. For CYD14, the IS consisted of a random sample of participants enrolled in the first 2 months of the trial (randomized 2:1 for inclusion), corresponding to ~20% of the total CYD14 participants; for CYD15, the IS consisted of a random sample of participants enrolled in the first 2 to 4 months of CYD15 (randomized 1:1 for inclusion), corresponding to ~10% of the total CYD15 participants. The sampling design for measurement of Month 13 MN titers in CYD14 and CYD15 participants is detailed in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0234236#pone.0234236.s008" target="_blank">S1 Text</a>. As in Moodie et al. [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0234236#pone.0234236.ref011" target="_blank">11</a>], cases are defined as participants who experienced the DENV-Any endpoint between Month 13 and Month 25. The table on the bottom shows the numbers of participants with nAb titer data available at Month 0 and at Month 13 in each trial, by case-control status.</p>

Cite this paper

APA 7

(8048906), L. N. C., (519951), Y. F., (3148182), M. B., (211088), Z. M., (688780), M. J., (53474), Y. H., (3434561), B. P., (1881535), Y. Z., (725172), J. S., (8975660), L. Z., (6083096), L. C., (5346035), R. S., (36740), S. S., (8486010), C. A. D., & (7431215), P. B. G. (2020). Case-cohort sampling scheme. Figshare. https://doi.org/10.1371/journal.pone.0234236.g002

MLA 9

(8048906), Lindsay N. Carpp, et al. “Case-cohort sampling scheme.” Figshare, 2020, https://doi.org/10.1371/journal.pone.0234236.g002.

Chicago

(8048906), Lindsay N. Carpp, Youyi Fong (519951), Matthew Bonaparte (3148182), Zoe Moodie (211088), Michal Juraska (688780), Ying Huang (53474), Brenda Price (3434561), et al. 2020. “Case-cohort sampling scheme.” Figshare. https://doi.org/10.1371/journal.pone.0234236.g002.

Harvard

(8048906), L.N.C. et al. (2020) ‘Case-cohort sampling scheme’, Figshare. Available at: https://doi.org/10.1371/journal.pone.0234236.g002.

BibTeX

@misc{80489062020case,
  title = {{Case-cohort sampling scheme.}},
  author = {(8048906), Lindsay N. Carpp and (519951), Youyi Fong and (3148182), Matthew Bonaparte and (211088), Zoe Moodie and (688780), Michal Juraska and (53474), Ying Huang and (3434561), Brenda Price and (1881535), Yingying Zhuang and (725172), Jason Shao and (8975660), Lingyi Zheng and (6083096), Laurent Chambonneau and (5346035), Robert Small and (36740), Saranya Sridhar and (8486010), Carlos A. DiazGranados and (7431215), Peter B. Gilbert},
  journal = {Figshare},
  year = {2020},
  doi = {10.1371/journal.pone.0234236.g002}
}

Made from the index record. Check names, capitalisation and page numbers against the paper. Need another style? AI for Research has over 10,000.